// App-Quantinova.ai

O10 : In early rheumatoid arthritis, trajectory of DAS28 progression is associated with poor patient reported outcomes: results from the SERA study

Researchers

Presenter

  • James Dale

Principal Investigators

  • Katie Druce

  • Duncan Porter

Medical Centers

  • Rheumatology, NHS Lanarkshire, Wishaw, United Kingdom

  • Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Manchester, United Kingdom

  • Department of Rheumatology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved